Depressive Symptom
9
4
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Nebulized Ketamine for the Treatment of Major Depressive Disorder
Integrative Therapeutic Programme to Regulate Expressed Emotions Among Informal Caregivers of People With Dementia
Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer
Digital Cognitive Behavioral Therapy for Chinese Adolescents With Depressive Symptoms（CADS-D )
Effectiveness of Individualized Automatic Coaching Message for Glycemic Management and Depressive Symptom
Musical Training to Enhance Resilience of Underprivileged School-aged Children
Cognicise Training for Seniors for Healthy Aging
Breathing Exercises on Depression in Postmenopausal Women
Auricular Concha Electro-acupuncture for the Treatment of Depression